Primary Care Enhanced Services
Overview
Summary, notice description and lot information
NHS Lincolnshire Integrated Care Board (ICB) is progressing with a Provider Selection Regime for awarding a contract related to Primary Care Enhanced Services, including general-practitioner services such as phlebotomy, treatment room services, and specialised drug monitoring. This contracting process is unfolding in the UKF3 region and adheres to the Health Care Services (Provider Selection Regime) Regulations 2023, bypassing the typical Public Contracts Regulations 2015. Currently in the award stage, NHS Lincolnshire ICB has yet to formally award the contract but has notified their intention, marking the commencement of a standstill period until representations close on 12 September 2025.
The contract is valued at £140,995, covering the period from 1 April 2025 to 31 March 2026, with the procurement method being direct award without prior publication. This tender represents a significant business opportunity for service providers within the healthcare sector, particularly those involved in delivering primary care and enhanced services. It emphasises elements such as quality, innovation, and social value, encouraging competition from businesses with strong capabilities in integration, collaboration, and service sustainability.
SMEs like Bourne Galletly Medical Practice, identified as the awarded supplier, highlight the potential for small-scale enterprises to boast their service delivery skills and expand under government-backed healthcare initiatives. Participation in such tenders allows businesses to grow by taking on public sector projects that align with their service offerings and expertise.
NHS Lincolnshire ICB is intending to utilise direct award process C of the Provider Selection Regime regulations to award a contract for the provision of: - Primary Care Enhanced Services, including: - Phlebotomy - Treatment Room - Pessaries - Warfarin - DOAC, Gonadorelins (Zoladex) - Specialised Drug Monitoring - Safeguarding - Minor Injuries - DVT Assessment & Management including D-Dimer Testing.
NHS Lincolnshire ICB is intending to utilise direct award process C of the Provider Selection Regime regulations to award a contract for the provision of: - Primary Care Enhanced Services, including: - Phlebotomy - Treatment Room - Pessaries - Warfarin - DOAC, Gonadorelins (Zoladex) - Specialised Drug Monitoring - Safeguarding - Minor Injuries - DVT Assessment & Management including D-Dimer Testing. The contract duration is from 1st April 2025 to 31st March 2026 and the expected value of the activity for the lifetime of the contract is PS140,995. The provider is an existing provider and the services are existing services.
Procurement Classification
Notice type, method, and CPV codes
Contract Values
Financial information and value estimates
Contract duration information not available.
Key Dates
Publication, submission, and award timeline
Notice Status
Current status of tender, lots, awards, and contracts
Contracting Authority
Buyer organisation and contact details
Awarded Supplier
Supplier who was awarded this contract
Documents & Links
External resources and data downloads
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector.
Need help with your tender submission?
Our expert team can help you prepare a winning bid. Get professional support from CareSync Experts.
Get in touch with our team at Care Sync Experts today for a consultation.
Email: hello@caresyncexperts.co.uk
Phone: 0333 577 0877
Contact UsBidding for contracts like this
Other tenders in North Kesteven
- Ageing Well Care Home Call-Off 100736728 in Rushcliffe
- Ageing Well Care Home Call-Off 5023853 in Rushcliffe
- Ageing Well Care Home Call-Off 101619826 in Rushcliffe
- Ageing Well Care Home Call-Off 101483488 in Rushcliffe
- Ageing Well Care Home Call-Off 2038561 in Rushcliffe
- Ageing Well Care Home Call-Off 101607272 in Rushcliffe